Nicodrops ads
This article was originally published in The Tan Sheet
Executive Summary
National print ads promoting the nicotine-free, herbal smoking cessation supplement Nicodrops Lozengewill begin appearing Aug. 8, eponymous firm announces. Ads in Ladies Home Journal, Woman's World, In Touch, the National Inquirer and three September issues of USA Today are expected to reach more than 10 mil. consumers, the firm notes. Certain ads will include a $2 mail-in rebate for the product. The La Mesa, Calif.-based company recently settled a lawsuit filed by GlaxoSmithKline that claimed Nicodrops made unfair and false claims and revised product packaging to remove comparisons to GSK's Commit smoking cessation lozenge (1"The Tan Sheet" June 13, 2005, p. 18)...
You may also be interested in...
US Q1 Consumer Health Earnings Preview: Label This One Historic And Challenging But Promising
US OTC drug and supplement firms’ reports of results for the first three months of 2024 began on April 19 with P&G. JP Morgan analysts say while “some retailers in the US in particular” are reducing consumer health inventories, for the overall sector they expect “a healthier balance of positive volume and lower pricing contribution.”
Keeping Track: Cancer Approvals From Lumisight Imaging To Adjuvant Alecensa
The US FDA’s approval of Lumicell’s optical imaging agent Lumisight makes a dozen novel approvals in 2024 for the Center for Drug Evaluation and Research.
Partisan Politics Returns To US FDA Congressional Oversight
The US FDA has stood out as an agency that tends to draw broad bipartisan support amid a generally rancorous and divided Congress. A House hearing, however, may be a sign that those days are over.